Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in United States (PLX3397)

Completed
Has Results
  • Solid Tumor
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Subjects Treated With ACTR T Cell Product

Terminated
  • B Cell Lymphomas
  • +3 more
  • ACTR T Cell Product
  • Gilbert, Arizona
  • +15 more
Oct 4, 2021

Metastasis in Lung, Metastasis in Liver, Solid Tumor Trial in United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Metastasis in Lung
  • +3 more
  • T3011
  • T3011 + pembrolizumab
  • Phoenix, Arizona
  • +3 more
Aug 26, 2021

Solid Tumor, Melanoma, NSCLC Trial in Australia, United States (T3011, T3011 + pembrolizumab)

Recruiting
  • Solid Tumor
  • +2 more
  • T3011
  • T3011 + pembrolizumab
  • Gilbert, Arizona
  • +7 more
Jun 22, 2021

Solid Tumor, HER-2 Protein Overexpression Trial in United States (ACTR T Cell Product, Trastuzumab)

Terminated
  • Solid Tumor
  • HER-2 Protein Overexpression
  • New Haven, Connecticut
  • +5 more
Mar 27, 2020

Solid Tumor Trial in United Kingdom, United States (ONO-7579)

Terminated
  • Solid Tumor
  • Lake Success, New York
  • +4 more
Sep 11, 2019

Solid Tumor Trial in United States (MSC2363318A, MSC2363318A plus Trastuzumab, MSC2363318A plus Tamoxifen)

Completed
  • Solid Tumor
  • Birmingham, Alabama
  • +14 more
Sep 18, 2018

Solid Tumor, Hodgkin's Lymphoma, NHL (Non-Hodgkin Lymphoma) Trial in Atlanta, Nashville, Dallas (INCB047986, Gemcitabine,

Terminated
  • Solid Tumor
  • +7 more
  • Atlanta, Georgia
  • +2 more
Jan 15, 2018

Solid Tumor, Breast Cancer, Ovarian Cancer Trial in Dallas, San Antonio (ATI-1123 (active drug = docetaxel))

Completed
  • Solid Tumor
  • +4 more
  • ATI-1123 (active drug = docetaxel)
  • Dallas, Texas
  • +1 more
Sep 4, 2012